Literature DB >> 16267678

Advances in short bowel syndrome: an updated review.

Igor Sukhotnik1, Arnold G Coran, Alexander Kramer, Eitan Shiloni, Jorge G Mogilner.   

Abstract

Short bowel syndrome (SBS) continues to be an important clinical problem due to its high mortality and morbidity as well as its devastating socioeconomic effects. The past 3 years have witnessed many advances in the investigation of this condition, with the aim of elucidating the cellular and molecular mechanisms of intestinal adaptation. Such information may provide opportunities to exploit various factors that act as growth agents for the remaining bowel mucosa and may suggest new therapeutic strategies to maintain gut integrity, eliminate dependence on total parenteral nutrition, and avoid the need for intestinal transplantation. This review summarizes current research on SBS over the last few years.

Entities:  

Mesh:

Year:  2005        PMID: 16267678     DOI: 10.1007/s00383-005-1500-z

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  57 in total

Review 1.  Gut adaptation and the glucagon-like peptides.

Authors:  D J Drucker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

2.  Truncated and native insulinlike growth factor I enhance mucosal adaptation after jejunoileal resection.

Authors:  J A Vanderhoof; R H McCusker; R Clark; H Mohammadpour; D J Blackwood; R F Harty; J H Park
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  Transplantation of gastrointestinal organs, including small intestine and stomach.

Authors:  R C Lillehei; W G Manax; G W Lyons; R H Dietzman
Journal:  Gastroenterology       Date:  1966-11       Impact factor: 22.682

4.  A prospective within-patient comparison clinical trial on the effect of parenteral cimetidine for improvement of fluid secretion and electrolyte balance in patients with short bowel syndrome.

Authors:  Junji Kato; Junichi Sakamoto; Satoshi Teramukai; Hiroshi Kojima; Akimasa Nakao
Journal:  Hepatogastroenterology       Date:  2004 Nov-Dec

5.  Gut adaptation and the insulin-like growth factor system: regulation by glutamine and IGF-I administration.

Authors:  T R Ziegler; M P Mantell; J C Chow; J L Rombeau; R J Smith
Journal:  Am J Physiol       Date:  1996-11

6.  Bombesin in short bowel syndrome.

Authors:  Ahmet Haldun Uluutku; Mehmet Levhi Akin; Yavuz Kurt; Ergun Yucel; Hakan Cermik; Kadir Avsar; Tuncay Celenk
Journal:  J Invest Surg       Date:  2004 May-Jun       Impact factor: 2.533

Review 7.  Intestinal rehabilitation and the short bowel syndrome: part 1.

Authors:  John K DiBaise; Rosemary J Young; Jon A Vanderhoof
Journal:  Am J Gastroenterol       Date:  2004-07       Impact factor: 10.864

8.  Sandostatin impairs postresection intestinal adaptation in a rat model of short bowel syndrome.

Authors:  Igor Sukhotnik; Kamal Khateeb; Michael M Krausz; Edmund Sabo; Leonardo Siplovich; Arnold G Coran; Eitan Shiloni
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

Review 9.  Intestinal adaptation in short-bowel syndrome.

Authors:  M J Lentze
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

10.  Glucagon-like peptide 2 is a potent growth factor for small intestine and colon.

Authors:  D A Litvak; M R Hellmich; B M Evers; N A Banker; C M Townsend
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

View more
  2 in total

1.  Nutritional supplementation with transforming growth factor-beta inhibits intestinal adaptation after massive small bowel resection in a rat.

Authors:  Igor Sukhotnik; Jorge G Mogilner; Shani Ben Lulu; Yulia Bashenko; Ron Shaoul; Elena Chemodanov; Arnold G Coran
Journal:  Pediatr Surg Int       Date:  2011-02       Impact factor: 1.827

2.  Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids.

Authors:  Stacy R Finkbeiner; Jennifer J Freeman; Minna M Wieck; Wael El-Nachef; Christopher H Altheim; Yu-Hwai Tsai; Sha Huang; Rachel Dyal; Eric S White; Tracy C Grikscheit; Daniel H Teitelbaum; Jason R Spence
Journal:  Biol Open       Date:  2015-10-12       Impact factor: 2.643

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.